Back to BlackRock, Inc. BlackRock, Inc.

AXSMAXSM
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AXSOME THERAPEUTICS INC

BlackRock, Inc. holds 3.1M shares of AXSM (AXSOME THERAPEUTICS INC), worth $759.7M as of 2026-Q2. The position was decreased (-20.7% shares). AXSM represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$759.7M

Current Shares

3.1M

Total Value Change

+$460.7M

Total Shares Change

-429,686

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.1M
-20.7%
$759.7M0.0%$244.77
0
2026-Q1
Decreased
3.9M
-0.0%
$661.3M0.0%$164.05
0
2025-Q4
Increased
3.9M
+3.2%
$714.8M0.0%$148.79
33
2025-Q3
Decreased
3.8M
-1.1%
$460.4M0.0%$117.62
0
2025-Q2
Increased
3.8M
+8.8%
$400.3M0.0%$103.36
34
2025-Q1
Decreased
3.5M
-0.3%
$411.1M0.0%$118.53
0
2024-Q4
New
3.5M
-
$299M0.0%$84.78
43

Other major holders of AXSM: VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used